11 minute read
Jun. 10, 2022
Acceleron’s TGF-beta Ligand Trap, Trillium’s SIRP-alpha Fusion Proteins, and Eight Other Large Molecules Acquired in 2021
Our team conducted a review of all of the biotech mergers and acquisitions of 2021 and distilled it down to the acquisitions of drug discovery-focused biotechs here. There were 10 acquisitions of companies with large molecule drug assets in 2021. Here is a more in-depth look into all of the lead large molecules acquired in 2021, including a review of:
The financial details of the acquisition/merger
The mechanism of action and indication of each lead molecule
The stage of clinical development for each lead molecule
Drug Discovery Biotech M&As: Large Molecules Deep Dive (Part 6)
Loading...